By Sheri Kasprzak
New York, March 13 - Helix BioMedix, Inc. said it has pocketed another $215,000 from its previously announced private placement, bringing the total proceeds to $2,598,000.
The company issued 215,000 shares and 21,800 warrants most recently for a total of 2,598,000 shares and 259,800 warrants.
Each warrant is exercisable at $1.00 for five years.
The first tranche of the deal closed March 7 for $2,383,000.
Proceeds will be used for research and development, for the out-licensing of the company's peptides and for general corporate purposes.
Based in Bothell, Wash., Helix BioMedix develops chemicals used in skin care products.
| Issuer: | Helix BioMedix, Inc.
|
| Issue: | Stock
|
| Amount: | $215,000
|
| Shares: | 215,000
|
| Price: | $1.00
|
| Warrants: | For 21,800 shares
|
| Warrant expiration: | Five years
|
| Warrant strike price: | $1.00
|
| Settlement date: | March 13
|
| Stock symbol: | OTCBB: HXBM
|
| Stock price: | $0.95 at close March 10
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
